Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anastasia Dagkonaki"'
Autor:
Irini Papazian, Maria Kourouvani, Anastasia Dagkonaki, Vasileios Gouzouasis, Lila Dimitrakopoulou, Nikolaos Markoglou, Fotis Badounas, Theodore Tselios, Maria Anagnostouli, Lesley Probert
Publikováno v:
eLife, Vol 12 (2024)
Autoimmune diseases of the central nervous system (CNS) such as multiple sclerosis (MS) are only partially represented in current experimental models and the development of humanized immune mice is crucial for better understanding of immunopathogenes
Externí odkaz:
https://doaj.org/article/a1739e6e5e644ae1b8dcd59cbe78ae6d
Autor:
Anastasia Dagkonaki, Athina Papalambrou, Maria Avloniti, Areti Gkika, Maria Evangelidou, Maria-Eleni Androutsou, Theodore Tselios, Lesley Probert
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Autoimmune diseases affecting the CNS not only overcome immune privilege mechanisms that protect neural tissues but also peripheral immune tolerance mechanisms towards self. Together with antigen-specific T cells, myeloid cells are main effector cell
Externí odkaz:
https://doaj.org/article/de53e7d0d54a481fb531d2b4f37bc68f
Autor:
Anastasia Dagkonaki, Maria Avloniti, Maria Evangelidou, Irini Papazian, Ioannis Kanistras, Vivian Tseveleki, Fotis Lampros, Theodore Tselios, Lise Torp Jensen, Wiebke Möbius, Torben Ruhwedel, Maria-Eleni Androutsou, John Matsoukas, Maria Anagnostouli, Hans Lassmann, Lesley Probert
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
CNS autoantigens conjugated to oxidized mannan (OM) induce antigen-specific T cell tolerance and protect mice against autoimmune encephalomyelitis (EAE). To investigate whether OM-peptides treat EAE initiated by human MHC class II molecules, we admin
Externí odkaz:
https://doaj.org/article/01e6e4ce64414d3fbec5f23cf0834a95
Autor:
Maria Evangelidou, Vivian Tseveleki, Ioannis Kanistras, Fotis Lampros, Hans Lassmann, Anastasia Dagkonaki, Maria-Eleni Androutsou, Irini Papazian, Theodore Tselios, Torben Ruhwedel, Lise T. Jensen, Maria Anagnostouli, Maria Avloniti, Lesley Probert, John Matsoukas, Wiebke Möbius
Publikováno v:
Frontiers in Immunology
Dagkonaki, A, Avloniti, M, Evangelidou, M, Papazian, I, Kanistras, I, Tseveleki, V, Lampros, F, Tselios, T, Jensen, L T, Möbius, W, Ruhwedel, T, Androutsou, M E, Matsoukas, J, Anagnostouli, M, Lassmann, H & Probert, L 2020, ' Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions ', Frontiers in Immunology, vol. 11, 575451 . https://doi.org/10.3389/fimmu.2020.575451
Frontiers in Immunology, Vol 11 (2020)
Dagkonaki, A, Avloniti, M, Evangelidou, M, Papazian, I, Kanistras, I, Tseveleki, V, Lampros, F, Tselios, T, Jensen, L T, Möbius, W, Ruhwedel, T, Androutsou, M E, Matsoukas, J, Anagnostouli, M, Lassmann, H & Probert, L 2020, ' Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions ', Frontiers in Immunology, vol. 11, 575451 . https://doi.org/10.3389/fimmu.2020.575451
Frontiers in Immunology, Vol 11 (2020)
CNS autoantigens conjugated to oxidized mannan (OM) induce antigen-specific T cell tolerance and protect mice against autoimmune encephalomyelitis (EAE). To investigate whether OM-peptides treat EAE initiated by human MHC class II molecules, we admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb7385b0b831c52b951e62281ba380d
http://europepmc.org/articles/PMC7711156
http://europepmc.org/articles/PMC7711156
Autor:
Maria-Eleni Androutsou, Theodore Tselios, Simona Golic Grdadolnik, Lesley Probert, Areti Gkika, Agathi Nteli, Anastasia Dagkonaki, Maria Avloniti
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 7566, p 7566 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 20
International Journal of Molecular Sciences
Volume 21
Issue 20
Mannan (polysaccharide) conjugated with a myelin oligodendrocyte glycoprotein (MOG) peptide, namely (KG)5MOG35&ndash
55, represents a potent and promising new approach for the immunotherapy of Multiple Sclerosis (MS). The MOG35&ndash
55 epi
55, represents a potent and promising new approach for the immunotherapy of Multiple Sclerosis (MS). The MOG35&ndash
55 epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489b243e2202de17b456403c458e80d7
https://www.mdpi.com/1422-0067/21/20/7566
https://www.mdpi.com/1422-0067/21/20/7566